BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 26602314)

  • 1. [Vesicular eruption in a patient under antituberculosis treatment].
    Garrido-Colmenero C; Ruiz-Villaverde R; Martínez-López A; Aneiros-Fernández J
    Med Clin (Barc); 2016 Mar; 146(5):e29. PubMed ID: 26602314
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lichenoid drug eruption with antituberculosis drugs associated with an anonychia].
    BayBay H; Saàdani C; Elloudi S; Douhi Z; Rimani M; Achour S; Mernissi FZ
    Ann Dermatol Venereol; 2020; 147(6-7):456-460. PubMed ID: 32229034
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antituberculosis agents.
    Goldberger MJ
    Med Clin North Am; 1988 May; 72(3):661-8. PubMed ID: 3280912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Eczematous-type multiple drug allergy from isoniazid and ethambutol with positive patch test results.
    Özkaya E
    Cutis; 2013 Sep; 92(3):121-4. PubMed ID: 24153138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Paradoxical worsening in tuberculosis during therapy in an HIV-infected patient.
    Mofredj A; Guérin JM; Leibinger F; Masmoudi R
    Infection; 1996; 24(5):390-1. PubMed ID: 8923052
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cutaneous reaction after pyrazinamide initiation].
    Mulliez P; Mbassi Fouda FL; Roy Saint-Georges F
    Med Mal Infect; 2011 Sep; 41(9):499-500. PubMed ID: 21458177
    [No Abstract]   [Full Text] [Related]  

  • 7. [Reasons for drug-resistant tuberculosis emergence].
    Tu DH
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Jun; 30(6):403-5. PubMed ID: 17673006
    [No Abstract]   [Full Text] [Related]  

  • 8. Two-month regimen of isoniazid, rifampin and pirazinamid for latent tuberculosis infection.
    Duarte R; Carvalho A; Correia A
    Public Health; 2012 Sep; 126(9):760-2. PubMed ID: 22633080
    [No Abstract]   [Full Text] [Related]  

  • 9. Safety of rifampin and pyrazinamide for the treatment of latent tuberculosis infection.
    Stout JE
    Expert Opin Drug Saf; 2004 May; 3(3):187-98. PubMed ID: 15155147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Fulminant hepatitis in the course of antitubercular treatment (apropos of 2 cases)].
    Mbaye PS; Talarmin F; Sane M; Eladari D; Klotz F
    Dakar Med; 1995; 40(2):129-31. PubMed ID: 9827070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course treatment regimens for patients with tuberculosis.
    Dutt AK; Stead WW
    Arch Intern Med; 1980 Jun; 140(6):827-9. PubMed ID: 6770770
    [No Abstract]   [Full Text] [Related]  

  • 12. [Surveillance and complications of antituberculosis chemotherapy].
    Duroux P
    Rev Prat; 1979 Jun; 29(33):2681-90. PubMed ID: 225779
    [No Abstract]   [Full Text] [Related]  

  • 13. Antituberculosis Treatment in a Patient with Celiac Disease.
    Cerezo Lajas A; Caminero Luna JA; Rodríguez Guzmán MDC; de Miguel Díez J
    Arch Bronconeumol (Engl Ed); 2018 Jun; 54(6):337-338. PubMed ID: 29426626
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis.
    Guo N; Marra F; Fitzgerald JM; Elwood RK; Marra CA
    Eur Respir J; 2010 Jul; 36(1):206-8. PubMed ID: 20595167
    [No Abstract]   [Full Text] [Related]  

  • 15. Incidence of serious side effects from first-line antituberculosis drugs among patients treated for active tuberculosis.
    Yee D; Valiquette C; Pelletier M; Parisien I; Rocher I; Menzies D
    Am J Respir Crit Care Med; 2003 Jun; 167(11):1472-7. PubMed ID: 12569078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Toxicity in the current treatment of pulmonary tuberculosis in children].
    Altet Gómez MN; Alcáide Megías J; Boque Genovard MA
    An Esp Pediatr; 1984 Jan; 20(1):18-27. PubMed ID: 6230974
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiple small bowel perforations in a patient on treatment of tuberculosis.
    Scriven JM; Berry D
    J R Coll Surg Edinb; 1996 Oct; 41(5):353. PubMed ID: 8908966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A rare case of isoniazid-induced erythroderma.
    Garg Y; Gore R; Jain S; Kumar A
    Indian J Pharmacol; 2015; 47(6):682-4. PubMed ID: 26729965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 20. The impact of chemotherapy on the care of patients with tuberculosis.
    Johnston RF; Wildrick KH
    Am Rev Respir Dis; 1974 Jun; 109(6):636-64. PubMed ID: 4209115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.